Mirum Pharmaceuticals, Inc. (MIRM)
93.33
-1.28
(-1.35%)
USD |
NASDAQ |
Nov 12, 16:00
93.22
-0.11
(-0.12%)
After-Hours: 20:00
Mirum Pharmaceuticals Profit Margin (Quarterly) : -21.95% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -21.95% |
| June 30, 2026 | -38.14% |
| March 31, 2026 | -494.2% |
| December 31, 2025 | -3.85% |
| September 30, 2025 | 2.18% |
| June 30, 2025 | -4.59% |
| March 31, 2025 | -13.15% |
| December 31, 2024 | -23.93% |
| September 30, 2024 | -15.75% |
| June 30, 2024 | -31.64% |
| March 31, 2024 | -36.52% |
| Date | Value |
|---|---|
| December 31, 2023 | -47.66% |
| September 30, 2023 | -49.42% |
| June 30, 2023 | -197.5% |
| March 31, 2023 | -95.35% |
| December 31, 2022 | -130.5% |
| September 30, 2022 | -190.1% |
| June 30, 2022 | -154.0% |
| March 31, 2022 | -283.9% |
| December 31, 2021 | |
| September 30, 2021 | -942.2% |
| June 30, 2021 | -399.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Incyte Corp. | -50.40% |
| Galectin Therapeutics, Inc. | -- |
| TG Therapeutics, Inc. | 21.34% |
| Ardelyx, Inc. | -0.58% |
| Kodiak Sciences, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -576.0% |
| Return on Assets | -98.45% |
| Return on Invested Capital | -138.9% |
| Gross Profit Margin (Quarterly) | 81.01% |
| Operating Margin (Quarterly) | -24.90% |
| Return on Net Operating Assets | -212.6% |